Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.04EUR
2.27 MEUR
174.53 MEUR
55.13 M
About Vanda Pharmaceuticals Inc.
Sector
CEO
Mihael Hristos Polymeropoulos
Headquarters
Washington
Website
Employees (FY)
203
Founded
2002
FIGI
BBG000P03LH3
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange VANDA PHARMAC.INC.DL-,001 stocks are traded under the ticker VM4.
VANDA PHARMAC.INC.DL-,001 is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
VM4 earnings for the last quarter are −0.06 EUR per share, whereas the estimation was 0.05 EUR resulting in a −240.00% surprise. The estimated earnings for the next quarter are 0.02 EUR per share. See more details about VANDA PHARMAC.INC.DL-,001 earnings.
VANDA PHARMAC.INC.DL-,001 revenue for the last quarter amounts to 43.99 M EUR despite the estimated figure of 44.95 M EUR. In the next quarter revenue is expected to reach 44.06 M EUR.
Yes, you can track VANDA PHARMAC.INC.DL-,001 financials in yearly and quarterly reports right on TradingView.
VM4 net income for the last quarter is −3.84 M EUR, while the quarter before that showed −2.17 M EUR of net income which accounts for −76.71% change. Track more VANDA PHARMAC.INC.DL-,001 financial stats to get the full picture.
No, VM4 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VM4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VANDA PHARMAC.INC.DL-,001 stock right from TradingView charts — choose your broker and connect to your account.
As of May 10, 2024, the company has 203.00 employees. See our rating of the largest employees — is VANDA PHARMAC.INC.DL-,001 on this list?
We've gathered analysts' opinions on VANDA PHARMAC.INC.DL-,001 future price: according to them, VM4 price has a max estimate of 4.86 EUR and a min estimate of 4.86 EUR. Watch VM4 chart and read a more detailed VANDA PHARMAC.INC.DL-,001 stock forecast: see what analysts think of VANDA PHARMAC.INC.DL-,001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VANDA PHARMAC.INC.DL-,001 EBITDA is −19.12 M EUR, and current EBITDA margin is −5.68%. See more stats in VANDA PHARMAC.INC.DL-,001 financial statements.